Is ZYNE or XYLD a better dividend investment in 2026?

ZYNE currently yields 153.85% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: ZYNE offers higher current income.

What is the dividend yield difference between ZYNE and XYLD?

ZYNE has a forward dividend yield of 153.85% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 142.87 percentage points.

Home › Compare › ZYNE vs XYLD

ZYNE vs XYLD: Dividend Comparison 2026

ZYNE yields 153.85% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZYNE wins by $28.41M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZYNE

● Live price

153.85%

Share price

$1.30

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.43M

Annual income

$12,477,713.99

Full ZYNE calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — ZYNE vs XYLD

📍 ZYNE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZYNE	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZYNE + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZYNE pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZYNE

Annual income on $10K today (after 15% tax)

$13,076.92/yr

After 10yr DRIP, annual income (after tax)

$10,606,056.89/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, ZYNE beats the other by $10,603,320.72/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZYNE + XYLD for your $10,000?

ZYNE: 50%XYLD: 50%

100% XYLD50/50100% ZYNE

Portfolio after 10yr

$14.23M

Annual income

$6,240,466.50/yr

Blended yield

43.86%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ZYNE right now

ZYNE

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-8.9

Piotroski

2/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZYNE buys

XYLD buys

No recent congressional trades found for ZYNE or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZYNEXYLD

Forward yield	153.85% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$28.43M ✓	$25.3K
Annual income after 10y	$12,477,713.99 ✓	$3,219.02
Total dividends collected	$26.36M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ZYNE vs XYLD ($10,000, DRIP)

Year	ZYNE Portfolio	ZYNE Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$26,085	$15,384.62	$10,818	$1,098.39	+$15.3K → ZYNE
2	$65,415	$37,504.84	$11,738	$1,222.51	+$53.7K → ZYNE
3	$157,896	$87,902.04	$12,774	$1,364.64	+$145.1K → ZYNE
4	$367,242	$198,293.18	$13,944	$1,527.86	+$353.3K → ZYNE
5	$823,976	$431,026.91	$15,270	$1,715.87	+$808.7K → ZYNE
6	$1,785,476	$903,821.11	$16,775	$1,933.09	+$1.77M → ZYNE
7	$3,740,825	$1,830,365.98	$18,490	$2,184.87	+$3.72M → ZYNE
8	$7,586,679	$3,583,996.66	$20,450	$2,477.63	+$7.57M → ZYNE
9	$14,910,849	$6,793,102.33	$22,697	$2,819.19	+$14.89M → ZYNE
10	$28,432,323	$12,477,713.99	$25,280	$3,219.02	+$28.41M → ZYNE

ZYNE vs XYLD: Complete Analysis 2026

ZYNE — Stock

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.

Full ZYNE Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this ZYNE vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZYNE vs SCHD ZYNE vs JEPI ZYNE vs O ZYNE vs KO ZYNE vs MAIN ZYNE vs QYLD ZYNE vs JEPQ ZYNE vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.